GET THE APP

Lupus: Open Access

Lupus: Open Access
Open Access

ISSN: 2684-1630

Perspective - (2023)Volume 8, Issue 4

Uncovering the Complexities of Alopecia

Kun Liu*
 
*Correspondence: Kun Liu, Department of Clinical Medicine, University of Science and Technology, Anhui, China, Email:

Author info »

Description

Alopecia refers to hair loss or the absence of hair from areas where it typically grows. It can affect various parts of the body, including the scalp, eyebrows, eyelashes, and body. There are several types of alopecia, but the most common is androgenetic alopecia, often referred to as male pattern or female pattern baldness. This type of alopecia is primarily genetic and related to hormone levels, especially Di Hydro Testosterone (DHT).

Lupus is a complex autoimmune disease. Autoimmune diseases occur when the immune system mistakenly attacks healthy tissues in the body, leading to inflammation and damage. Lupus specifically involves the immune system attacking various organs and tissues, causing a wide range of symptoms and complications. Systemic Lupus Erythematosus (SLE) is the most common and severe form of lupus, but there are other types as well, such as cutaneous lupus erythematosus, which primarily affects the skin

Systemic Lupus Erythmatosus have several symptoms, Alopecia is one of them.

In Cutaneous Lupus Erythematosus (CLE) some individuals with lupus develop skin related symptoms, including rashes and lesions. In particular, those with Cutaneous Lupus Erythematosus (CLE) experience skin inflammation. This can lead to scarring, skin damage, and hair loss in affected areas. Therefore, alopecia can be a symptom of CLE in individuals with lupus.

During medications people with lupus often receive treatment to manage their symptoms. Some medications used in lupus treatment, such as corticosteroids and immunosuppressive drugs, may have side effects that include hair loss. It's important for healthcare providers to carefully consider these side effects when prescribing medications for lupus patients.

As a Shared Immune Dysregulation (DIS) both alopecia and lupus are believed to involve dysregulation of the immune system. In alopecia areata, a specific type of alopecia, the immune system targets hair follicles, leading to hair loss. Similarly, in lupus, the immune system targets various tissues and organs. The commonality lies in the immune system's inability to distinguish between self and foreign substances, resulting in attacks on healthy tissues.

Stress as a trigger in patients of Cutaneous Lupus Erythematosus (CLE) stress can exacerbate both alopecia and lupus. High levels of stress can trigger or worsen autoimmune responses. Individuals with lupus may experience increased disease activity during periods of stress, which can contribute to hair loss.

Alopecia cause symptoms in individuals with lupus. Alopecia can present as a symptom in various ways such as Scarring Alopecia(SA). In some cases, lupus-related skin inflammation can lead to scarring alopecia, where hair follicles are replaced by scar tissue. This type of alopecia can be irreversible. Non Scarring Alopecia(NSA) Non-scarring alopecia in lupus is typically associated with Cutaneous Lupus Erythematosus (CLE). In this case, hair loss is usually temporary and may improve with appropriate treatment for lupus. Diffuse Hair Thinning(DHT) some individuals with lupus may experience diffuse hair thinning rather than localized bald patches. This can be challenging to distinguish from common male pattern or female pattern baldness.

Diagnosing alopecia in individuals with lupus involves a combination of clinical evaluation and sometimes additional tests. A dermatologist or rheumatologist, who specializes in autoimmune diseases like lupus, may assess the extent of hair loss, examine the scalp, and consider the patient's medical history. In some cases, a scalp biopsy or blood tests may be necessary to rule out other causes of hair loss and confirm the presence of lupus-related alopecia.

Treatment include the approach to treating alopecia in individuals with lupus depends on the specific type of alopecia and the underlying lupus activity. Here are some common strategies Managing Lupus Activity include controlling lupus through medication and lifestyle management is essential to minimize the autoimmune response, which can help alleviate alopecia symptoms. Topical Corticosteroids is used for Non- Scarring Alopecia associated with lupus, topical corticosteroid creams or solutions may be prescribed to reduce inflammation and promote hair regrowth. Systemic Corticosteroids are used in severe cases of lupus-related alopecia, oral or intravenous corticosteroids may be necessary to suppress the autoimmune response. However, long-term use of systemic steroids can have significant side effects and is generally avoided when possible. Immunosuppressive Medications are used in some cases, immunosuppressive drugs like azathioprine or methotrexate may be prescribed to control lupus and potentially improve alopecia symptoms. Hair Restoration Treatments like hair transplantation or other hair restoration techniques may be considered in cases of scarring alopecia once lupus activity is under control. Psychological support is very important as dealing with hair loss can be emotionally challenging. Patients with lupus-related alopecia may benefit from psychological support and counseling to cope with the impact on their self-esteem and mental wellbeing. Lupus and alopecia are just two examples of autoimmune diseases, which collectively affect millions of individuals worldwide. Autoimmune diseases share common features, such as immune system dysfunction and inflammation, and they often coexist in the same individual. Understanding these connections is crucial for both research and clinical practice. Diagnosing and managing alopecia in individuals with lupus requires a comprehensive approach that addresses both conditions.

Author Info

Kun Liu*
 
Department of Clinical Medicine, University of Science and Technology, Anhui, China
 

Citation: Liu K (2023) Uncovering the Complexities of Alopecia: Lupus: Open Access. 8:251

Received: 26-Jul-2023, Manuscript No. LOA-23-26142; Editor assigned: 28-Jul-2023, Pre QC No. LOA-23-26142(PQ); Reviewed: 11-Aug-2023, QC No. LOA-23-26142; Revised: 21-Aug-2023, Manuscript No. LOA-23-26142(R); Accepted: 28-Aug-2023 , DOI: 10.35248/2684-1630.23.8.251

Copyright: © 2023 Liu K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Top